Related Experiment Video
Updated: Aug 9, 2025

Using RNA-interference to Investigate the Innate Immune Response in Mouse Macrophages
Published on: November 3, 2014
miRNA-Induced Downregulation of IPMK in Macrophages Mediates Lipopolysaccharide-Triggered TLR4 Signaling
Haein Lee1, Eunha Kim1, Seyun Kim1,2,3
1Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.
Abstract:
Inositol polyphosphate multikinase (IPMK) is a pleiotropic enzyme responsible for the production of inositol polyphosphates and phosphoinositide. IPMK in macrophages was identified as a key factor for the full activation of the Toll-like receptor 4 (TLR4) signaling pathway and inflammation by directly interacting with tumor necrosis factor receptor-associated factor 6 (TRAF6). Here, dynamic changes of IPMK levels in lipopolysaccharide (LPS)-stimulated macrophages and their functional significance were investigated. Both the mRNA and protein levels of IPMK were acutely decreased in mouse and human macrophages when cells were stimulated with LPS for between 1 and 6 h. Analysis of the 3' untranslated region (UTR) of mouse IPMK mRNA revealed a highly conserved binding site for miR-181c. Transfection of miR-181c mimics into RAW 264.7 macrophages led to decreased IPMK 3'UTR-luciferase reporter activity and lowered endogenous IPMK levels. When the genomic deletion of a 33-bp fragment containing a putative miR-181c-binding site was introduced within the IPMK 3'UTR of RAW 264.7 macrophages (264.7Δ3'UTR), LPS-triggered downregulation of IPMK levels was prevented. LPS treatment in 264.7Δ3'UTR macrophages decreased TLR4-induced signaling and the expression of proinflammatory cytokines. In response to LPS stimulation, K63-linked ubiquitination of TRAF6 was impaired in 264.7Δ3'UTR macrophages, suggesting an action of IPMK in the suppression of TRAF6 activation. Therefore, our findings reveal that LPS-mediated suppression of IPMK regulates the full activation of TLR4 signaling and inflammation in macrophages.
Insights
Lipopolysaccharide (LPS) acutely decreases inositol polyphosphate multikinase (IPMK) in macrophages via miR-181c, suppressing Toll-like receptor 4 (TLR4) signaling and inflammation. Restoring IPMK levels prevents this suppression, highlighting IPMK
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Inositol polyphosphate multikinase (IPMK) is crucial for inositol phosphate production.
- IPMK in macrophages is vital for Toll-like receptor 4 (TLR4) pathway activation and inflammation.
- IPMK interacts with tumor necrosis factor receptor-associated factor 6 (TRAF6) in TLR4 signaling.
Purpose of the Study:
- To investigate the dynamic changes in IPMK levels during lipopolysaccharide (LPS)-stimulated macrophages.
- To elucidate the functional significance of IPMK regulation in macrophage activation.
- To identify the molecular mechanisms controlling IPMK expression in response to LPS.
Main Methods:
- Quantitative analysis of IPMK mRNA and protein levels in LPS-stimulated mouse and human macrophages.
- MicroRNA (miR-181c) binding site analysis in the 3' untranslated region (UTR) of IPMK mRNA.
- Luciferase reporter assays and gene editing (CRISPR/Cas9) in RAW 264.7 macrophage cell lines.
- Assessment of TLR4 signaling, TRAF6 ubiquitination, and pro-inflammatory cytokine expression.
Main Results:
- LPS stimulation led to acute downregulation of both IPMK mRNA and protein in macrophages.
- A conserved miR-181c binding site in the IPMK 3'UTR was identified, mediating LPS-induced suppression.
- Genetic deletion of the miR-181c binding site in the IPMK 3'UTR prevented LPS-triggered IPMK reduction.
- Macrophages with a modified IPMK 3'UTR exhibited impaired TLR4 signaling, reduced TRAF6 activation, and decreased pro-inflammatory cytokine production.
Conclusions:
- LPS-mediated suppression of IPMK, regulated by miR-181c, is a critical mechanism controlling TLR4 signaling and inflammation in macrophages.
- IPMK plays a key role in the full activation of the TLR4 pathway by modulating TRAF6 activation.
- Targeting the IPMK-miR-181c axis offers potential therapeutic strategies for inflammatory diseases.
More Related Videos
07:55A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces
Published on: January 7, 2020
11:48Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
Related Concept Videos
Formation of Lipopolysaccharides
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
IP3/DAG Signaling Pathway